In contrast, in a pancreatic cancer model using mice transgenic for αSMA thymidine kinase, elimination of αSMA myofibroblasts resulted in more aggressive tumors and decreased animal survival (Özdemir et al., 2014). The gene discussed is ACTA1; the disease is familial pancreatic carcinoma.